A 6 week quadruple drug regimen for the treatment of multibacillary leprosy

Leprosy Review

Volumn 71, Issue 1, 2000, Pages 43-46

  Pattyn, S ^a   Grillone, S ^b  

^a INSTITUTE OF TROPICAL MEDICINE   (Belgium)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CLINAFLOXACIN; CLOFAZIMINE; DAPSONE; ETHIONAMIDE; MINOCYCLINE; OFLOXACIN; RIFAMPICIN; TROVAFLOXACIN;

ARTICLE; CLINICAL TRIAL; FOLLOW UP; HUMAN; LEPROSY; MAJOR CLINICAL STUDY; MOUTH DISEASE; PRACTICE GUIDELINE; RECURRENCE RISK; SKIN DISCOLORATION;

CLOFAZIMINE; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; LEPROSTATIC AGENTS; LEPROSY; MALE; MINOCYCLINE; MYCOBACTERIUM LEPRAE; OFLOXACIN; RIFAMPIN; TREATMENT OUTCOME;

EID: 0034057849     PISSN: 03057518     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Ji B. Why multidrug therapy for multibacillary leprosy can be shortened to 12 months. Lepr. Rev., 1998; 69: 106-109.
2. Pattyn SR, Groenen G, Janssens L, Deverchin J, Ghys P. Combined regimens of one year duration in the treatment of multibacillary leprosy. I Combined regimens with rifampicin administered during one year. Lepr. Rev., 1989; 60: 109-117.
3. Pattyn SR, Bourland J, Kazeze. Ambulatory treatment of multibacillary leprosy with a regimen of 8 months duration. Lepr. Rev., 1992; 63: 36-40.
4. Pattyn SR, Groenen G, Janssens L, Kuykens L, Mputu MB. Treatment of multibacillary leprosy with a regimen of 13 weeks duration. Lepr. Rev., 1992; 63: 41-46.
5. Pattyn SR. Activity of ofloxacin and pefloxacin against Mycobacterium leprae in mice. Antimicrob Agents Chemother., 1987; 31: 671-672.
6. Pattyn SR. Antimycobacterium leprae activity of several quinolones studied in the mouse. Int. J. Lepr., 1991; 59: 613-617.
7. Gelber RH. Activity of minocycline in Mycobacterium leprae-infected mice. J. Infect. Dis., 1987; 156: 236-239.
8. Xiong J, Ji B, Perani EG, Petinon C, Grosset JH. Further study of the infectiveness of single doses of clarithromycin and minocycline against Mycobacterium leprae in mice. Int. J. Lepr., 1994; 62: 37-42.
9. Ji B, Jamet P, Sow S, Perani EG, Traore I, Grosset JH. High relapse rate among lepromatous leprosy patients treated with rifampin plus ofloxacin daily for 4 weeks. Antimicrob. Agents Chemother., 1999; 41: 1953-1956.
10. Ganapati R, Pai VV, Revankar CR, Kingsley S, Buichand HO. Relapse of multibacillary leprosy after rifampin and ofloxacin treatment for 28 days; a case report. Int. J. Lepr., 1998; 66: 56-57.
11. Jamet P, Ji B and the Marchoux Chemotherapy Study Group. Relapse after long-term follow-up of multibacillary patients treated by WHO multidrug regimen. Int. J. Lepr., 1994; 63: 195-201.
12. Ji B, Jamet P, Perani EG, Bobin P, Grosset JH. Powerful bactericidal activities of clarithromycin and minocycline against Mycobacterium leprae in lepromatous leprosy. J. Infect. Dis., 1993; 169: 188-190.
13. Gelber RH, Siu P, Tsang M, Alley P, Murray LP. Effect of low level and intermittent minocycline therapy on the growth of Mycobacterium leprae in mice. Antimicrob. Agents Chemother., 1991; 35: 992-994.
14. Eisen D, Hakim MD. Minocycline-induced pigmentation. Incidence, prevention and management. Drug Saf., 1998; 18: 431-440.
15. Morrow GL, Abbott RL. Minocycline-induced scleral, dental, and dermal pigmentation. Am. J. Ophthalmol., 1998; 125: 396-397.
16. Pattyn SR. Search for effective short course regimens for the treatment of leprosy with a regimen of 8 months duration. Int. J. Lepr., 1992; 60: 234-243.
17. Wayne LG, Sramek HA. Metronidazole is bactericidal to dormant cells of Mycobacterium tuberculosis. Antimicrob. Agents Chemother., 1994; 38: 2054-2058.
18. Wayne LG. Dormancy of Mycobacterium tuberculosis and latency of disease. Eur. J. Clin. Microbiol. Infect. Dis., 1994; 13: 908-914.
19. Wayne LG, Hayes LG. An in vitro model for sequential study of shiftdown of Mycobacterium tuberculosis through two stages of non-replicating persistence. Infect. Immun., 1996; 64: 2062-2069.